Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Br J Haematol. 2014 Mar 3;165(4):504–509. doi: 10.1111/bjh.12778

Table II.

Non-Haematological Adverse Events (Grade 3–5) Possibly Related to Treatment

Adverse Event Grade
3 4 5
ALT increased 4 1 0
AST increased 3 3 0
Abdominal pain 1 0 0
Acute kidney injury 0 1 0
Alkaline phosphatase 1 0 0
Anorexia 1 0 0
Cardiac arrest 0 0 2
Catheter-related infection 2 0 0
Diarrhoea 2 0 0
ECG QTc 1 0 0
Encephalopathy 2 0 0
Enterocolitis 2 0 0
Febrile neutropenia 16 1 0
Gum infection 1 0 0
Hepatic failure 0 1 0
Hypercalcaemia 0 1 0
Hyperglycaemia 1 0 0
Hyperkalaemia 1 0 0
Hypertension 1 0 0
Hypocalcaemia 1 0 0
Hypokalaemia 1 0 0
Hyponatraemia 1 0 0
Hypophosphataemia 1 0 0
Hypotension 2 0 0
Hypoxia 1 1 0
Infections (other) 1 0 0
Lung infection 3 1 0
Nervous system disorders 1 0 0
Oral pain 1 0 0
Respiratory failure 0 1 0
Sepsis 0 3 1
Tooth infection 1 0 0
Tumour lysis syndrome 1 0 0
Typhilitis 2 0 0

ALT, analine transaminase; AST, aspartate transaminase; ECG, electrocardiogram.